Search
for
Sort by
Research 121–150 of 1000+
- 13. Wound Healing & Hair
- JAK-Inhibitors Beyond the Label: Emerging Applications in Dermatology
- A linear and reticulate crusted keratotic papulopustular eruption: a rare presentation of PRIDE (Papulopustules and/or paronychia, Regulatory abnormalities of hair growth, Itching, and Dryness due to Epidermal growth factor receptor inhibitors) complex
- A decade of neglecting sublingual mass: A case report of epidermoid cyst
- Acquired Localized Hypertrichosis Induced by Rivastigmine
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- A case of neurodermatitis circumscipta of scalp presenting as patchy alopecia
- Off-label uses of retinoids in dermatology
- An urticarial drug eruption caused by tofacitinib for alopecia universalis
- Repurposing FDA approved drugs for psoriasis indications through integrated molecular docking, one-SVM algorithm, and molecular dynamics simulation approaches
- Dermatologic Manifestations of Human Immunodeficiency Virus Infection
- Metastatic Melanoma of the Tongue: A Rare Case
- Therapeutic Applications of Nanoemulsion Based Drug Delivery Systems: A Review of Patents in Last Two Decades
- Therapeutic Application of Microsponges-based Drug Delivery Systems
- Regenerative Medicine of Epidermal Structures
- 4. Bullous/Mucous Membrane
- Protolytic Equilibria of Cetirizine in the Presence of Micelle-Forming Surfactants
- A case of atopic dermatitis with alopecia universalis in a patient treated with abrocitinib
- Allergen‐specific immunotherapy improves alopecia totalis in a severe atopic dermatitis patient
- Black Hairy Tongue Syndrome: Case Report and Review of the Literature
- Prescription Pattern in Dermatological Conditions of the Pediatric Population
- The Pathological Culprit of Neuropathic Skin Pain in Long COVID-19 Patients: A Case Series
- Advances in Chitosan-Based Nanoparticles for Drug Delivery
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Docking and Molecular Dynamics Identify Leads against 5 Alpha Reductase 2 for Benign Prostate Hyperplasia Treatment
- Beyond cancer treatment: dermo-aesthetic and other wellness recommendations for breast cancer patients
- Biologics in the management of childhood atopic dermatitis
- Melatonin in Dermatologic Allergic Diseases and Other Skin Conditions: Current Trends and Reports
- Optimizing clinical monitoring and management guidelines for capivasertib in HR-positive/HER2-negative advanced breast cancer: expert opinion
- Unveiling the Potential of Dermoscopy in Diagnosing Netherton Syndrome